Test Price
2,800 AED✅ Home Collection Available
JPH2 Gene Cardiomyopathy (Familial Hypertrophic Type 17) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
Accredited Next‑Generation Sequencing · Home Collection · 3–4 Weeks TAT
تحليل جين JPH2 لاعتلال عضلة القلب الضخامي العائلي من النوع 17 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain & VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in Result Interpretation.
Insurance: Direct Billing Verification via WhatsApp
+971 54 548 8731
الفحص الجيني لجين JPH2 بموجب معايير هيئة الصحة بدبي والمرسوم بقانون اتحادي رقم 41 لعام 2024. دقة تشخيصية عالية مع سحب منزلي آمن ومعتمد، نتائج خلال 3–4 أسابيع. الامتثال الكامل لقانون حماية البيانات الشخصية الإماراتي وقانون المسؤولية الطبية للمُعالَجين القُصَّر.
1. Overview of the Test
The JPH2 gene NGS test screens for pathogenic variants causing familial hypertrophic cardiomyopathy type 17, a genetic heart muscle disease. It provides precise molecular diagnosis to guide clinical management and family risk assessment.
فحص تسلسل جين JPH2 يُحدد الطفرات الوراثية المسببة لاعتلال عضلة القلب الضخامي العائلي من النوع 17، مما يساعد الأطباء في توجيه العلاج والوقاية الأسرية.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Method | Next‑Generation Sequencing (all exons + flanking regions) | Sanger sequencing of known familial variant only |
| Detection Sensitivity | 99.9% diagnostic sensitivity, novel mutation detection | ~95% for targeted site, cannot identify new mutations |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks (if variant already known) |
| Sample Collection | Home‑based cold‑chain phlebotomy, also accepts DNA/FTA card | Clinic visit usually required |
2. Physician Insight & Safety Protocol
“As a cardiogenetic specialist, I stress that a pathogenic JPH2 variant must be correlated with your echocardiogram, ECG, and family history. Never interpret this result in isolation. Please discuss all findings with your treating cardiologist before making any lifestyle or treatment changes. Sudden cardiac risk is serious, and expert guidance is your strongest protection.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning
Do not discontinue prescribed heart medications (beta‑blockers, calcium channel blockers, diuretics) without consulting your doctor. This genetic test is a diagnostic tool, not a substitute for ongoing cardiac care.
Clinical Exclusion Criteria (Per UAE CDS Law 2026 & DHA Protocols)
- Minors (under 18 years) without a parent/legal guardian present for informed consent, as required by Federal Decree‑Law No. 41 of 2024, Article 87, and UAE Child Protection Laws.
- Severe cognitive impairment or active psychiatric condition preventing valid informed consent.
- Recent blood transfusion (within 2 weeks) that may introduce donor DNA interference.
- Known contraindication to phlebotomy (severe bleeding disorder, unstable acute illness).
🚨 Emergency Red Flags – Seek Immediate Medical Attention
- Sudden chest pain, pressure, or tightness
- Shortness of breath that worsens with minimal activity or at rest
- Fainting (syncope) or near‑fainting episodes, especially during exertion
- Forceful, irregular heartbeat or palpitations lasting more than a few minutes
If you experience any of these, call 998 (UAE ambulance) or go to the nearest emergency department immediately.
3. Patient FAQ & Clinical Guidance
Q: What exactly does the JPH2 genetic test detect?
This test sequences the entire JPH2 gene to identify disease‑causing mutations linked to hypertrophic cardiomyopathy type 17, giving you a definitive molecular diagnosis. (Snippet: The JPH2 NGS panel detects pathogenic variants causing familial hypertrophic cardiomyopathy, enabling early intervention and family screening.)
Q: Who should consider this genetic test?
You should test if you have a family history of hypertrophic cardiomyopathy, unexplained heart muscle thickening, or a known JPH2 variant in a relative. (Snippet: Individuals with familial HCM, suspicious echocardiograms, or relatives of JPH2 mutation carriers benefit most from this targeted DNA analysis.)
Q: How is the sample collected and what safety measures are in place?
A DHA‑licensed phlebotomist visits your home with a sterile, cold‑chain kit to draw a small blood sample; you may also provide DNA on an FTA card. (Snippet: Home blood collection uses a closed, chilled transport system guaranteeing sample integrity, and the entire process follows UAE infection control standards.)
س: ما هي دواعي إجراء تحليل جين JPH2؟
يُوصى بهذا الفحص لكل من لديه تاريخ عائلي للإصابة باعتلال عضلة القلب الضخامي أو أعراض قلبية غير مفسرة، أو عند وجود طفرة معروفة في جين JPH2 لدى أحد الأقارب. (ملخص الإجابة: تحليل جين JPH2 يكشف الطفرات الوراثية المسببة لاعتلال العضلة القلبية الضخامي العائلي، مما يدعم التشخيص المبكر والإرشاد الوراثي للعائلة.)
Essential Pre‑Test Requirements
A detailed clinical and family history must be recorded, including a three‑generation pedigree. Our service includes a mandatory pre‑ genetic counselling session (telephonic or face‑to‑face) to explain the implications, inheritance pattern, and possible outcomes. No sample will be processed without documented informed consent, in accordance with UAE Federal Law No. 41 of 2024 and international genetic testing guidelines.
يشترط تقديم تاريخ طبي عائلي كامل وجلسة إرشاد وراثي قبل الفحص، وفقاً للتشريعات الإماراتية الحديثة.
For same‑day booking or insurance verification, contact us on WhatsApp: +971 54 548 8731
Facility License: 9834453 | ISO 9001:2015 Certified | All data handled as per UAE PDPL
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians